News & stories

News | Oct 29, 2020

Four steps to an affordable and accessible COVID-19 vaccine

This pandemic will not be over until it’s over for everyone.

News | Oct 29, 2020

MSF responds to Gavi’s intent to purchase COVID-19 vaccine candidate from Sanofi and GlaxoSmithKline

Calls for greater transparency: "There is no room for secrets during a pandemic"

News | Oct 08, 2020

MSF: Moderna’s decision to not enforce COVID-19 vaccine patents during the pandemic isn’t enough

News | Oct 07, 2020

India and South Africa propose no patents on COVID-19 medicines and tools during the pandemic

News | Jul 28, 2020

Cepheid charges four times more than it should per COVID-19 test

Pharmaceutical corporation overcharges and undersupplies WHO effort to test people for COVID-19 in developing countries

News | Jun 23, 2020

MSF: Gavi must ensure COVID-19 vaccines produced through its new global fund for vaccine development are affordable for people everywhere

Pharmaceutical corporations that get money from Gavi for new COVID-19 vaccines must sell them at cost

News | Jun 19, 2020

India: MSF opens 100-bed COVID-19 treatment center in Bihar

News | Jun 03, 2020

Gavi to release funds from pneumonia vaccine subsidy to manufacturer of more affordable vaccine

News | Jun 02, 2020

MSF: Any future COVID-19 vaccines must be affordable and accessible for all

Governments are set to give pharmaceutical corporations billions to create new vaccines without attaching strings to make sure they are affordable or available for everyone, everywhere once they hit the market

News | May 29, 2020

MSF welcomes WHO solidarity call for equitable global access to COVID-19 tools

Initiative is an important first step, but governments must make binding commitments to guarantee access